in a long-term double-blind , randomized placebo-controlled study of combination therapy , serum glucose , c-peptide , total cholesterol , triglyceride , low-density lipoprotein cholesterol , very-low-density lipoprotein cholesterol , and high-density lipoprotein cholesterol concentrations were evaluated in insulin-treated patients with poorly controlled , type ii diabetes mellitus after addition of either glyburide ( n = 10 ) or placebo ( n = 12 ) .
C0011860
type ii diabetes mellitus
C0017628
glyburide